ARCHIVES

“Whatever Happened To…?” ACS Follows Up Five Years Later

This article is from The Cancer Letter archive.

Vol. 03 No. 34 | August 26, 1977

Download PDF Visit The Full Archive

Related Articles

ASCO Guideline On Breast Cancer Risk Reduction Updated

May 29, 2009

Budesonide Not Beneficial For Diarrhea In Melanoma

August 28, 2009

Patients on Hypertension Meds Lived Longer, Analysis Shows

January 31, 2014

FDA Advisors Unanimously Turn Down GPC Biotech’s Orplatna for Prostate Cancer.

July 27, 2007

Letters: NCI Mammography Statement Recognizes Patient Autonomy

February 25, 1994

NCI Plans $30 Million In Patient-Oriented Chemoprevention research In Next 5 Years

December 6, 1996